The Global Nicotinamide Mononucleotide Hydride (NMNH) Market was valued at USD 159 Million in 2025 and is projected to reach USD 279 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period (2024–2030). This remarkable growth is fueled by the global anti-aging supplement boom, rising research on NAD+ precursors, and expanding pharmaceutical applications for metabolic health interventions.

As the longevity science sector evolves with groundbreaking discoveries about cellular health, leading biotechnology firms and ingredient suppliers are competing to produce high-purity NMNH – the reduced, more bioavailable form of β-NMN that serves as a direct NAD+ precursor. In this analysis, we examine the Top 10 Companies Shaping the NMNH Industry through their production capabilities, research investments, and commercial distribution networks.

Download FREE Sample Report: Nicotinamide Mononucleotide Hydride (NMNH) Market – View in Detailed Research Report

---

🔟 1. ChromaDex Corp.

Headquarters: Los Angeles, California, USA
Key Offering: Pharmaceutical-grade NMNH, TRU NIAGEN® NAD+ supplement line

A pioneer in NAD+ research, ChromaDex leverages its extensive scientific expertise to produce high-purity NMNH for clinical research and premium supplement formulations. Their patented technologies and collaborations with research institutions position them as innovation leaders.

Key Advantages:

• Holds foundational patents covering manufacturing processes
• Active in over 150 clinical studies on NAD+ precursors
• Strategic partnerships with academic research centers

---

9️⃣ 2. Hygieia Biotech

Headquarters: Hangzhou, China
Key Offering: Large-scale NMNH production, API-grade material

This Chinese biotech firm has emerged as the largest producer of NMNH in Asia, with fermentation facilities capable of metric ton-scale output. Hygieia supplies bulk material to global nutraceutical brands and pharmaceutical companies.

Key Advantages:

• Cost-competitive enzymatic production process
• GMP-certified manufacturing facilities
• Vertically integrated supply chain

---

8️⃣ 3. EffePharm Co., Ltd

Headquarters: Nanjing, China
Key Offering: High-purity NMNH powders, customized formulations

Specializing in NAD+ precursors, EffePharm has developed proprietary stabilization technology for NMNH that enhances shelf life while maintaining bioavailability. Their products serve supplement brands worldwide.

Key Advantages:

• Advanced stabilization technology for sensitive molecules
• Strict quality control (purity levels >98%)
• Customized formulation services

Download FREE Sample Report: Nicotinamide Mononucleotide Hydride (NMNH) Market – View in Detailed Research Report

---

7️⃣ 4. Bontac Bio-Engineering

Headquarters: Shenzhen, China
Key Offering: NMNH raw material, private label supplement solutions

Bontac combines enzyme engineering expertise with large-scale manufacturing to produce affordable NMNH for the mass market while serving premium customers with cGMP-grade material.

Key Advantages:

• Hybrid chemical-enzymatic synthesis approach
• Vertical integration from raw materials to finished products
• White-label manufacturing services

---

6️⃣ 5. Bicells Science Ltd

Headquarters: Shanghai, China
Key Offering: Ultra-pure NMNH, analytical testing services

Focusing on research-grade NMNH, Bicells serves pharmaceutical companies and universities with some of the purest material available (≥99% purity), backed by comprehensive analytical verification.

Key Advantages:

• Superior purity specifications
• Comprehensive analytical characterization
• Specialized in small-batch research quantities

---

5️⃣ 6. Xi’an Green Biotechnique

Headquarters: Xi’an, China
Key Offering: NMNH bulk powder, custom capsule formulations

This established manufacturer has been scaling up NMNH production rapidly to meet growing demand from global supplement brands, particularly in North American and European markets.

Key Advantages:

• Specialized in custom dosage forms (capsules, tablets)
• Exports to over 30 countries
• Competitive pricing for bulk purchases

Download FREE Sample Report: Nicotinamide Mononucleotide Hydride (NMNH) Market – View in Detailed Research Report

---

4️⃣ 7. InnovaSyn Biotech Inc.

Headquarters: Ottawa, Canada
Key Offering: Innovative NMNH delivery systems, licensed IP

A technology-driven company, InnovaSyn focuses on advanced NMNH formulations with improved bioavailability, including liposomal and nanoparticle delivery systems.

Key Advantages:

• Proprietary delivery technologies
• Strong patent portfolio
• Pharma partnership model

---

3️⃣ 8. Bonerge Lifescience

Headquarters: Xi’an, China
Key Offering: NMNH in various particle sizes, co-formulations

Specializing in technical innovation, Bonerge develops optimized NMNH variants for different applications and has expanded capacity significantly in recent years.

Key Advantages:

• Micronization and particle engineering expertise
• Fast scaling capabilities
• Stable supply chain

---

2️⃣ 9. Provita Biotech

Headquarters: Shandong, China
Key Offering: Cost-competitve NMNH, private label services

Provita focuses on delivering reliable NMNH at competitive prices for supplement brands looking to enter the NAD+ booster market with affordable products.

Key Advantages:

• Economies of scale
• Strict quality control systems
• Full service from formulation to packaging

---

1️⃣ 10. Xi’an Haoze Biotechnology

Headquarters: Xi’an, China
Key Offering: NMNH raw material, contract manufacturing

A rising producer in China’s Shaanxi province, Haoze Biotech has been expanding its NMNH production capacity to meet growing international demand.

Key Advantages:

• New state-of-the-art facility
• Focus on export markets
• Technical support services

Get Full Report Here: Nicotinamide Mononucleotide Hydride (NMNH) Market – View in Detailed Research Report

---

🧬 Outlook: The Future of NMNH is Clinical Validation and Formulation Innovation

The NMNH market is transitioning from a niche supplement ingredient to a clinically validated molecule with therapeutic potential. As research advances, key trends are emerging:

📈 Market-Shaping Developments:

• Pharmaceutical companies exploring NMNH for metabolic and neurological conditions
• Advanced delivery systems improving bioavailability and efficacy
• Increasing clinical trials validating health benefits and safety
• Growing investment in large-scale production capacity

The companies profiled above are at the forefront of transforming NMNH from a longevity supplement to an evidence-based therapeutic agent with applications across healthcare and wellness.

Get Full Report Here: Nicotinamide Mononucleotide Hydride (NMNH) Market – View in Detailed Research Report